# Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment

> **NCT00828438** · PHASE1 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** Lorcaserin 10mg

## Key facts

- **NCT ID:** NCT00828438
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828438, "Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00828438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*